Product Information
BANOPHEN 50 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0298 per EA under NDC 00904530780. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904530780
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
11/2/2009
Pharmacological Classes
Price Statistics
The NADAC for BANOPHEN 50 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 51.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0298 per EA |
|---|---|
| All-time high | $0.0316 (Jul 15, 2026) |
| All-time low | $0.0176 (May 19, 2021) |
| 52-week high | $0.0316 |
| 52-week low | $0.0219 |
| Median price | $0.0225 |
| Average price | $0.0225 |
| Largest weekly change | +35.2% (Feb 23, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diphenhydramine hcl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BANOPHEN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BANOPHEN 50 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0298 per EA (NDC 00904530780), effective Sep 30, 2026.
How has the price of BANOPHEN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BANOPHEN 50 MG CAPSULE has risen 51.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BANOPHEN 50 MG CAPSULE?
Since Nov 28, 2013, the NADAC for BANOPHEN 50 MG CAPSULE has ranged from a low of $0.0176 (May 19, 2021) to a high of $0.0316 (Jul 15, 2026), with a median of $0.0225 per EA.
Are there cheaper alternatives to BANOPHEN 50 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BANOPHEN 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BANOPHEN 50 MG CAPSULE?
BANOPHEN 50 MG CAPSULE (NDC 00904530780) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.